ICON First Large CRO to Fully Integrate Medidata Clinical Data Studio
Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions, has announced that ICON plc (NASDAQ: ICLR), a global clinical research organization (CRO) specializing in healthcare intelligence, is the first large CRO to fully integrate Medidata Clinical Data Studio into its clinical trial workflows. This milestone marks a significant step forward in data management, streamlining clinical operations and enhancing decision-making processes.
By incorporating Clinical Data Studio, ICON is leveraging the full potential of the Medidata Data Experience. This integration enables the seamless merging of data from both Medidata and non-Medidata sources, allowing for faster decision-making and AI-powered risk assessment for clinical trial sites and sponsors. Clinical Data Studio, built on Medidata’s advanced AI and automation technologies, enhances data aggregation, standardization, and management. It grants ICON real-time access to trial data, fostering improved cross-functional collaboration, operational oversight, and a unified strategy for executing clinical trials more efficiently and with higher quality outcomes.
ICON’s leadership in risk-based quality management is underscored by its integration of Data Management and Central Monitoring teams within its Clinical Data Science group. The adoption of Clinical Data Studio reflects ICON’s commitment to addressing increasing data demands and meeting customer expectations for speed and efficiency. The platform streamlines data review, central monitoring, and medical review processes by leveraging AI and statistical modeling, ensuring faster and more precise data delivery.
“ICON leads in risk-based quality management, integrating Data Management and Central Monitoring teams in our Clinical Data Science group. To meet growing data demands and customer expectations for speed and efficiency, we selected Clinical Data Studio. This platform streamlines data review, central monitoring, and medical review processes using AI and statistical modeling for faster, precise data delivery,” said Evan Hughes, Vice President, Clinical Data Science, ICON.
Tom Doyle, Chief Technology Officer at Medidata, added, “With our AI-powered Clinical Data Studio, ICON is reimagining clinical data science, maximizing efficiency, speed, and quality. We’re providing the technology and capabilities that empower ICON and their customers to unlock unprecedented insights and accelerate the delivery, at scale, of life-changing therapies to patients worldwide.”
The collaboration between Medidata and ICON is built on a 20-year partnership, during which Medidata has supported ICON in over 1,700 studies, with more than 400 currently active. These studies span therapeutic areas such as oncology, central nervous system disorders, and vaccine therapies. ICON has also employed Medidata’s eCOA and Medidata Designer to optimize clinical operations and enhance collaboration between sponsors, sites, and patients.
About Medidata
Medidata is committed to advancing smarter treatments and healthier patient outcomes through digital solutions for clinical trials. With 25 years of technological innovation spanning more than 35,000 trials and over 11 million patients, Medidata provides expertise, analytics-driven insights, and the world’s largest patient-level historical clinical trial dataset. Trusted by approximately 2,300 customers and over 1 million registered users, Medidata’s end-to-end platform accelerates clinical breakthroughs and optimizes patient experiences. A brand of Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City. More information is available at www.medidata.com, and updates can be followed on @Medidata.
About Dassault Systèmes
Dassault Systèmes is dedicated to driving human progress through virtual technology solutions. Since 1981, the company has pioneered innovations that improve real-world applications for consumers, patients, and businesses. The 3DEXPERIENCE platform supports 370,000 customers across various industries, enabling them to collaborate, innovate, and create sustainable solutions. For more information, visit www.3ds.com.
About ICON plc
ICON plc is a leading healthcare intelligence and clinical research organization. Specializing in outsourced clinical research services for pharmaceutical, biotechnology, medical device, and government organizations, ICON is dedicated to advancing emerging therapies and improving patient lives. Headquartered in Dublin, Ireland, ICON employs approximately 41,190 professionals across 106 locations in 55 countries as of December 31, 2024. Further details about ICON can be found at www.iconplc.com.
The integration of Medidata Clinical Data Studio into ICON’s operations represents a paradigm shift in clinical research, enhancing efficiency, improving data management, and ultimately expediting the development of life-saving therapies.
